Literature DB >> 14678203

Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid.

Colin MacNeill1, Todd M Umstead, David S Phelps, Zhenwu Lin, Joanna Floros, Debra A Shearer, Judith Weisz.   

Abstract

Surfactant protein A (SP-A), first identified as a component of the lung surfactant system, is now recognized to be an important contributor to host defence mechanisms. SP-A can facilitate phagocytosis by opsonizing bacteria, fungi and viruses, stimulate the oxidative burst by phagocytes and modulate pro-inflammatory cytokine production by phagocytic cells. SP-A can also provide a link between innate and adaptive immune responses by promoting differentiation and chemotaxis of dendritic cells. Because of the obvious relevance of these mechanisms to the host defence and 'gate keeping' functions of the lower genital tract, we examined human vaginal mucosa for SP-A protein and transcripts and analysed vaginal lavage fluid for SP-A. By immunocytochemistry, SP-A was identified in two layers of the vaginal epithelium: the deep intermediate layer (the site of newly differentiated epithelial cells); and the superficial layer (comprising dead epithelial cells), where SP-A is probably extracellular and associated with a glycocalyx. Transcripts of SP-A were identified by Northern blot analysis in RNA isolated from vaginal wall and shown, by sequencing of reverse transcription-polymerase chain reaction products, to be derived from each of the two closely related SP-A genes, SP-A1 and SP-A2. SP-A was identified in vaginal lavage fluid by two-dimensional gel electrophoresis, and confirmed by mass spectrometry. This study provides evidence, for the first time, that SP-A is produced in a squamous epithelium, namely the vaginal mucosa, and has a localization that would allow it to contribute to both the innate and adaptive immune response. The findings support the hypothesis that in the vagina, as in lung, SP-A is an essential component of the host-defence system. A corollary hypothesis is that qualitative and quantitative alterations of normal SP-A may play a role in the pathogenesis of lower genital tract inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678203      PMCID: PMC1782386          DOI: 10.1111/j.1365-2567.2004.01782.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells.

Authors:  C R Wira; R M Rossoll; C Kaushic
Journal:  Endocrinology       Date:  2000-08       Impact factor: 4.736

2.  Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein.

Authors:  J Floros; R Steinbrink; K Jacobs; D Phelps; R Kriz; M Recny; L Sultzman; S Jones; H W Taeusch; H A Frank
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

3.  Migration of lymphocytes in the normal human vagina.

Authors:  M H Burgos
Journal:  Am J Obstet Gynecol       Date:  1968-12-15       Impact factor: 8.661

4.  Influence of local estrogen administration in vaginal glycogen.

Authors:  T R Wrenn; J Bitman; J R Wood
Journal:  Endocrinology       Date:  1968-01       Impact factor: 4.736

Review 5.  Immunology of the vagina.

Authors:  S S Witkin
Journal:  Clin Obstet Gynecol       Date:  1993-03       Impact factor: 2.190

6.  HLA-DR-expressing Langerhans'-like cells in vaginal and cervical epithelium.

Authors:  S Bjercke; H Scott; L R Braathen; E Thorsby
Journal:  Acta Obstet Gynecol Scand       Date:  1983       Impact factor: 3.636

Review 7.  Host defences and the vaginal mucosa. A re-evaluation.

Authors:  M S Cohen; J R Black; R A Proctor; P F Sparling
Journal:  Scand J Urol Nephrol Suppl       Date:  1984

8.  Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation.

Authors:  Charles R Wira; Marcie A Roche; Richard M Rossoll
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

9.  Proline hydroxylation alters the electrophoretic mobility of pulmonary surfactant-associated protein A.

Authors:  D S Phelps; J Floros
Journal:  Electrophoresis       Date:  1988-05       Impact factor: 3.535

10.  Morphometric characteristics of cells in the alveolar region of mammalian lungs.

Authors:  J D Crapo; S L Young; E K Fram; K E Pinkerton; B E Barry; R O Crapo
Journal:  Am Rev Respir Dis       Date:  1983-08
View more
  38 in total

1.  Surfactant protein-A (SP-A) selectively inhibits prostaglandin F2alpha (PGF2alpha) production in term decidua: implications for the onset of labor.

Authors:  Victoria V Snegovskikh; Vineet Bhandari; Jo Rae Wright; Serkalem Tadesse; Thomas Morgan; Colin Macneill; Nastaran Foyouzi; Joong Shin Park; Yuguang Wang; Errol R Norwitz
Journal:  J Clin Endocrinol Metab       Date:  2011-01-26       Impact factor: 5.958

2.  The innate immune system: gatekeeper to the female reproductive tract.

Authors:  Charles R Wira; John V Fahey
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

3.  Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy.

Authors:  Deug-Chan Lee; Roberto Romero; Chong Jai Kim; Tinnakorn Chaiworapongsa; Adi L Tarca; JoonHo Lee; Yeon-Lim Suh; Shali Mazaki-Tovi; Edi Vaisbuch; Pooja Mittal; Sorin Draghici; Offer Erez; Juan Pedro Kusanovic; Sonia S Hassan; Jung-Sun Kim
Journal:  J Immunol       Date:  2010-05-03       Impact factor: 5.422

Review 4.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

5.  Surfactant protein A is defective in abrogating inflammation in asthma.

Authors:  Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-22       Impact factor: 5.464

Review 6.  Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.

Authors:  Frederico Vieira; Johannes W Kung; Faizah Bhatti
Journal:  Ann Anat       Date:  2017-03-27       Impact factor: 2.698

Review 7.  Recent progress on surfactant protein A: cellular function in lung and kidney disease development.

Authors:  Skylar D King; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

Review 8.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

Review 9.  Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Gene       Date:  2012-10-12       Impact factor: 3.688

10.  The concentration of surfactant protein-A in amniotic fluid decreases in spontaneous human parturition at term.

Authors:  Tinnakorn Chaiworapongsa; Joon-Seok Hong; William M Hull; Chong Jai Kim; Ricardo Gomez; Moshe Mazor; Roberto Romero; Jeffrey A Whitsett
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.